A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Clinical trial NCT05021120 · COMPLETED
Trial details
- NCT number
- NCT05021120
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2024-10-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.